SHANDONG YUANDA FUBANG BIOENGINEERING CO., LTD is a modern high-tech biopharmaceutical enterprise that integrates research and development, production, sales, and service of veterinary drugs. The company was established in 2003, with 8 provincial-level and municipal level scientific and technological innovation platforms such as "Shandong New R&D Institutions", 26 invention patents, and 27 high-level and cutting-edge professional and technical talents, including 1 expert in the "National Key Talent Project", 2 experts in the "Hundred Talents Plan of the Chinese Academy of Sciences", 2 international technical experts, and 22 doctoral and master's students.

The company has been awarded the titles of "National Intellectual Property Advantage Enterprise", "National High tech Enterprise", "Hidden Champion Enterprise in Shandong Province", "Specialized, Refined, and New Enterprise in Shandong Province", "Shandong Science and Technology Small and Medium sized Enterprise", "Shandong Integrity Construction Demonstration Enterprise", "Shandong Intellectual Property Demonstration Enterprise", "Top Ten Veterinary Medicine Brand Enterprises in Shandong Province", and "Top Ten Chinese Veterinary Medicine Brand Enterprises in Shandong Province" Multiple honorary titles include "Advanced Work Unit of Shandong Veterinary Association", "Top 100 Innovative Private Enterprises in Weifang City", and "Top 50 Social Responsibility Enterprises in Weifang".

The company has a 5000 square meter highly standardized GMP workshop, with advanced production equipment and a high degree of automation, fully constructed in accordance with the new version of GMP regulations. The company mainly produces livestock and poultry drugs, health products, especially injections and Chinese medicine super micro powder. The product sales range covers more than 20 provinces, and some products are exported to Southeast Asia and African countries.

In 2020, with a total investment of over 60 million yuan, the Zhongke Libang Bioengineering Research Institute was established, which is a research institution specializing in the field of high-tech biopharmaceuticals. The research institute mainly conducts research on related projects such as "genetic engineering drugs, new vaccine products, biological diagnostic reagents, biosynthesis technology, biogenic technology, biological fermentation technology, screening of advantageous strains, biosafety evaluation, and clinical trial evaluation".

The product research and development is backed by China Science and Technology Lipang Biotechnology Research Institute, and we adhere to the product concept of "innovative research and development, focus on details, and lead the development of the enterprise with perfect product quality" to create the future of the enterprise, and contribute to the healthy development of China's animal husbandry.